A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy

NCT01438567 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Constipation

Interventions

DRUG: oxycodone/naloxone prolonged release (OXN PR) tablets
DRUG: oxycodone prolonged release (OxyPR) tablets

Sponsor

Mundipharma Research GmbH & Co KG